首页 | 本学科首页   官方微博 | 高级检索  
     

左归丸对去卵巢大鼠股骨中核心结合因子α1 mRNA表达的影响
引用本文:王艳杰,任艳玲,宋囡,吕海波,李亚玲. 左归丸对去卵巢大鼠股骨中核心结合因子α1 mRNA表达的影响[J]. 中国实验方剂学杂志, 2013, 19(13): 191-195
作者姓名:王艳杰  任艳玲  宋囡  吕海波  李亚玲
作者单位:1. 辽宁中医药大学基础医学院,沈阳,110032
2. 辽宁中医药大学附属第二医院,沈阳,110034
3. 山东世博金都药业有限公司北京医药研发中心,北京,100070
4. 鹤壁职业技术学院医学院,河南鹤壁,458030
基金项目:国家自然科学基金项目(30873226);教育部高等学校博士学科点专项科研基金(20102133110001);辽宁省教育厅创新团队项目(LT2010068);辽宁省科技厅自然基金(201102148)
摘    要:目的:观察左归丸对去卵巢骨质疏松大鼠股骨中核心结合因子α1 mRNA表达的影响,探讨其对骨质疏松的防治机制.方法:280只SPF级SD雌性大鼠,分为3组:正常组40只、假手术组40只、其余采取双侧背部卵巢切除术进行绝经后骨质疏松症造模.21 d后,随机分为5组:模型组、尼尔雌醇组、左归丸高、中、低剂量组.左归丸高、中、低剂量组分别给予ig6.4,3.2,1.6 g·kg-1剂量的左归丸混悬液,1次/d;尼尔雌醇组ig尼尔雌醇混悬液0.21 mg·kg-1,每周1次.于连续给药60,120,180 d,分别取大鼠左后肢股骨近端1/3部分,采用RT-PCR方法测定核心结合因子α1的mRNA表达水平.结果:与正常组比较,模型组股骨中核心结合因子α1 mRNA水平明显降低(P<0.01);和模型组比较,给药60,120,180 d的左归丸各剂量组,股骨中核心结合因子α1 mRNA水平显著升高(P<0.05).结论:骨组织中核心结合因子α1 mRNA表达水平的下调可能是PMOP发生的重要机制之一,左归丸能够上调骨组织中核心结合因子α1 mRNA表达,从而有效防治骨质疏松.

关 键 词:左归丸  骨质疏松症  核心结合因子α1
收稿时间:2012-12-25

Expressions of Core Binding Factor Alpha 1 mRNA of Femoral Organization by Zuogui Pill in Ovariectomy-induced Osteoporosis Rats
WANG Yan-jie,REN Yan-ling,SONG Nan,LV Hai-bo and LI Ya-ling. Expressions of Core Binding Factor Alpha 1 mRNA of Femoral Organization by Zuogui Pill in Ovariectomy-induced Osteoporosis Rats[J]. China Journal of Experimental Traditional Medical Formulae, 2013, 19(13): 191-195
Authors:WANG Yan-jie  REN Yan-ling  SONG Nan  LV Hai-bo  LI Ya-ling
Affiliation:Liaoning University of Traditional Chinese Medicine, Shenyang 110032,China;Liaoning University of Traditional Chinese Medicine, Shenyang 110032,China;Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110034,China;Shandong Shibojindu Pharmacentical Ltd,Beijing 100070, China;Hebi Institute of Technology Medical College, Hebi 458030,China
Abstract:Objective:To observe the expression of core binding factor alpha 1 mRNA of femoral organization by Zuogui Pill in ovariectomy-induced osteoporosis rats. Method: Two hundred and eighty male SPF SD rats were divided into three groups:normal group 40;sham-operated group 40;ovariectomy-induced osteoporosis model was adopted, 21 days later, randomly modeling rats were divided into 5 groups:the model group, nilestriol group, Zuogui Pill high, medium, low dose group. Zuogui Pill groups were ig given with Zuogui Pill at dosage of 6.4, 3.2, 1.6 g·kg-1, once per day. Nilestriol group was treated with Nilestriol liquid. The normal group, sham-operated group and the model group were given with distilled water.60, 120, 180 d later, the expression of core binding factor alpha 1 in the femoral organization was determined by RT-polymerase chain reaction (PCR). Result: Compared with the normal group, in the model group the femoral core binding factor alpha 1 mRNA level obviously reduced (P<0.01). And compared with the model group, Zuogui Pill groups increased femoral core binding factor alpha 1 mRNA level significantly(P<0.05). Conclusion: The down-regulated expression of core binding factor alpha 1 mRNA of bone tissue may be contributed to PMOP, Zuigui Pill can up-regulated mRNA expression.
Keywords:Zuogui Pill  osteoporosis  core binding factor alpha 1
本文献已被 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号